Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 5 EP applications Sarah Louise Thompson has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13195499

Complexes of IL-15 and IL-15R alpha and uses thereof

IPC classification:
A61K 39/395, C07K 16/00
Applicant:
Novartis AG
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jones Day
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13195495

Complexes of IL-15 and IL-15R alpha and uses thereof

IPC classification:
A61K 39/395
Applicant:
Novartis AG
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jones Day
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP15706583

IMPACT OF GENETIC FACTORS ON DISEASE PROGRESSION AND RESPONSE TO ANTI-C5 ANTIBODY IN GEOGRAPHIC ATROPHY

IPC classification:
C12Q 1/68
Applicant:
Novartis AG
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15795063

COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY

IPC classification:
A61K 39/00, C07K 16/28
Applicant:
Novartis AG
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Status:
Request for examination was made
EP15784870

COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY

IPC classification:
A61K 39/00, C07K 16/28
Applicant:
Novartis AG
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Status:
Request for examination was made

Please Sign in to use this feature